PHS
EW icon

PFM Health Sciences’s Edwards Lifesciences EW Stock Holding History

PFM Health Sciences’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-525,400
Closed -$38.9M – 74
2024
Q4 		$38.9M Buy
+525,400
New +$36.8M 2.41% 13
2019
Q2 		– Sell
-469,500
Closed -$29.9M – 91
2019
Q1 		$29.9M Buy
+469,500
New +$26.8M 0.66% 55

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

PFM Health Sciences's EW Position: Q1 2026 in Review

PFM Health Sciences increased its Edwards Lifesciences (EW) stake by 3.1% in Q1 2026, buying an estimated $633K and bringing the position to 254,510 shares worth $20.4M. The position accounts for 1.86% of the portfolio, ranked #15.

PFM Health Sciences first reported a position in EW in Q4 2014 and has held it in 46 quarters since. The position peaked at $127M in Q2 2015. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • PFM Health Sciences held 254,510 shares of Edwards Lifesciences worth $20.4M as of Q1 2026.
  • PFM Health Sciences bought 7,675 Edwards Lifesciences shares in Q1 2026, an estimated $633K.
  • Edwards Lifesciences made up 1.86% of PFM Health Sciences's portfolio in Q1 2026, its #15 holding.
  • PFM Health Sciences first reported a position in Edwards Lifesciences in Q4 2014 and has held it in 46 quarters since.
  • PFM Health Sciences's Edwards Lifesciences position peaked at $127M in Q2 2015.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on PFM Health Sciences's 13F filing for Q1 2026, filed 15 May 2026.